CytoSorbents Corp (NAS:CTSO)
$ 0.9366 0.0166 (1.8%) Market Cap: 51.47 Mil Enterprise Value: 72.59 Mil PE Ratio: 0 PB Ratio: 3.95 GF Score: 68/100

Q3 2024 Cytosorbents Corp Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMT
Release Date Price: $0.898529 (-1.76%)
Operator

Thank you for standing by. My name is Catherine and I will be your conference operator today. At this time. I would like to welcome everyone to the site of Cytosorbents Corporation third quarter, 2024 earnings call. (Operator Instructions)

Thank you. I would now like to turn the call over to Investor Relations consultant, Adana Alexander. Please go ahead.

Unidentified Company Representative

Thank you, Katherine and good afternoon, everyone, welcome to side the SOS third quarter, 2024 financial and operating results conference call. Joining me today from the company for the prepared remarks are of Phillip Chan, Chief Executive Officer; and Pete Mariani, Chief Financial Officer for the Q&A portion of the call. Dr. Chan and Mr, Mariani will be joined by Phil Capone, President and Chief Operating Officer, Doctor Micas da Gis, Chief Medical Officer, Dr Christian Steiner, Executive Vice President of sales and marketing and managing director of Stos Europe and Christian Kramer, Senior Vice President of Business Development.

Before I turn the call over to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot